Conference on Pharmaceutics and Advanced Drug Delivery Systems (aac) A

Event Information

Share this event

Date and Time

Location

Location

Venue will be informed to the Registered Participants

TBA

00100 Rome

Italy

View Map

Event description
CPD Accredited International Conference on Pharmaceutics and Advanced Drug Delivery Systems

About this Event

Theme

Pioneering the Development in Drug Discovery and Design

Allied academies proudly announce the commencement of its International Conference on Pharmaceutics and Advanced Drug Delivery Systems" which is going to be held in Rome, Italy on February 24-25, 2020. The conference highlights the theme "Pioneering the Development in Drug Discovery and Design". The event establishes a very good platform with its well organized scientific program to the audience which includes keynote lectures, interactive panel discussions, plenary talks and poster sessions on the novel drug delivery, formulations, toxicity, pharmaceutical innovations in the recent era, and new scientific approaches to international regulatory standards.

The conference invites noble laureates, delegates from top universities, pharmaceutical companies, scientists, researchers, business delegates, health care professionals, students and young researchers across the globe providing a better podium about the latest technologies, research development as well as in the therapeutic aspects which give a lot of information where it is the best chance to meet eminent personalities in the field of pharmaceuticals.

It gives a lot of information on the latest research development about the novel drug development, this can be the best chance to achieve the most important assemblage of participants from the pharmacology community, meet the current and potential scientists, and also the information about novel drug delivery system, drug targeting, molecular modeling, and computer aided drug designing.

The sessions of this conference are more concerned with drug delivery technology, novel drug delivery systems, novel routes of administration, pharmaceutical nanotechnology, nucleic acid-based drug delivery, smart drug delivery, vaccine design, and delivery technology, drug delivery companies, and markets, biopharmaceutics as a novel the technique in drug delivery, drug devices and device development, peptide and protein drug delivery, drug delivery equipment’s and machinery.

Purpose of attending:

It gives a lot of information on the latest research development about the novel drug development, this can be the best chance to achieve the most important assemblage of participants from the pharmacology community, meet the current and potential scientists and also the information about novel drug delivery system, drug targeting, molecular modeling, and computer aided drug designing.

Target Audience:

· Students, Scientists, Research scholars and Faculties from Pharmacy Universities and Medical Colleges

· Research scientists from Pharmaceutical Industries

· Pharmacy associations and societies

· Business Entrepreneurs Training Institutes

· Software developing companies

· Medical devices manufacturing companies

· Clinical Research Organizations

· Data Management Companies.

Conference Highlights

  • Drug Formulation
  • Formulation of R&D
  • Pharmacokinetics and Pharmacovigilance
  • Pharmaceutical Nanotechnology
  • Pharmacodynamics
  • Pharmacological science
  • Drug Delivery Technology
  • Toxicology
  • Pharmacogenomics
  • Advanced Drug Delivery System
  • Green Sustainable Pharma
  • Proteomics in Drug Discovery
  • Pharmacognosy and Phytochemistry
  • Digital Pharma
  • Control of Quality of Analytical Methods
  • Pharmaceutical Manufacturing
  • Bio-availability and Bio-equivalence
  • Pharmaceutical Chemistry
  • Biologics and Biosimilars
  • Nanomedicine and Biomedical Applications
  • Encapsulated Drugs
  • Pharmacy Law and Ethics

Sessions and Tracks

Session 1: Drug Formulation

Pharmaceutical formulation is defined as the process in which different chemical substances are combined to produce a final medicinal product which can be either solid, semisolid or liquid formulations. This session is ventured around topics like Drug Delivery design, the versatile polymer in drug delivery and Controlled Drug Delivery, Novel Drug interactions, improvement of pharmaceutical product, Sustained Drug Delivery Systems, maybe a distinct architecture session that plays an important role in the fields of drug formulation and development.

Session 2: Formulation of R&D

The drug is subjected to a number of trials and is screened at different stages to produce a final vigorous drug intended for the treatment of various diseases. During this process, the drug various properties are checked if it is non-toxic to a living system and is therapeutic or not. Using various suitable excipients and technological preparations the active substances are developed into the final dosage form. The product formed at last is the Actual composition of preparation, manufacturing specification. Due to drug formulation, it can have a considerable impact on almost every characteristic of an API such as potency, bioavailability, solubility, dosage, route of administration and stability. R&D services are provided for the primary stage and preclinical candidates with special prominence in nanoparticle-based drug delivery technology.

Session 3: Pharmacokinetics and Pharmacovigilance

Pharmacokinetics deals with bodily absorption, distribution, metabolism, and excretion of drugs. The fundamental concept in pharmacokinetics is about clearance of drugs, in simple words, it can be described as the removal of drugs from the body. Knowledge of pharmacokinetic principles helps prescribers alter dose additional accurately and rapidly.

Pharmacovigilance is known by other names as drug safety. It’s the pharmacological science related to the collection, detection, assessment, monitoring, and prevention of adverse effects with any drug-related problem. Pharmacovigilance officers are one who monitors, assess, detect, and prevent the adverse effects of pharmaceutical products.

Session 4: Pharmaceutical Nanotechnology

Pharmaceutical Nanotechnology handles with new arriving technologies for developing customized solutions or modified answers for drug delivery systems. The framework shows positive impacts on the rate of retention, circulation, digestion, and discharge of the drug Compound or other related compound substances in the body. Pharmaceutical nanotechnology grasps uses of Nanoscience to the drug store as a nanomaterial and as gadgets like Novel Drug conveyance, analytics, imaging, and biosensor.

Session 5: Pharmacodynamics

In this session, the discussion is about the impact of drug or the response of the body to the drug. The keynote of this session is to clarify the connection between measurement and reaction (tranquilize impacts). The mechanism behind pharmacodynamics is about the interaction of the drug with tissue receptors which is placed either in cell membranes or in the intracellular fluid. The main objective is to keep up the specialized novel entity and target the best possible remedial rate just by staying away from poisonous quality while giving a unification of the medication to give crave impacts.

Session 6: Pharmacological Science

Pharmacology is a branch that is concern about the study of drugs. This session is to clarify about drugs origin, nature, chemistry, nature of effects, etc. This session consists of Pharmacognosy, pharmacokinetics, pharmacodynamics, pharmacotherapeutics and, toxicology. The different terms of pharmacological sciences are Behavioural pharmacology, Medical Pharmacology, Cardiovascular Pharmacology, Endocrine Pharmacology, Clinical Pharmacology, Urogenital pharmacology, Pharmacokinetics, Neuropharmacology, Immune pharmacology, Cognitive models of the brain, Neural models of memory, Functional modes of the brain, Neuropsychology, Cognitive neuroscience and, neuro systems, Clinical Pharmacology.

Session 7: Drug Delivery Technology

Pharmaceutical drug delivery technologies not only enhanced the drug absorption, efficacy but also patient experience. In drug delivery technology taste maskers increase the commercial growth by neutralizing the strong, bitter tastes of certain oral medical formulations. Bioavailability of pharmaceuticals can be proficiently achieved inside the framework can be accomplished by enhancing drug delivery technology. The main courses of drug delivery are oral, injection/infusion, and transdermal. Drug-eluting stents and other implantable drug delivery devices are presented, and they are externally applied devices.

Session 8: Toxicology

Toxicology is a discipline, overlying with biology, chemistry, pharmacology, and medicine, that involves the study of the negative effects of chemical substances on living organisms and the practice diagnosing of and treating exposures to toxins and toxicants. It explains the link between dose and its effects on the exposed organism. The link between dose and its effects is very significant to toxicology. The factors that influence chemical toxicity consists of the dosage (and whether it is acute or chronic), route of exposure, species, age, sex, and environment. The session discusses the toxic impact of a novel drug when it is gathered excessively than the rate.

Session 9: Pharmacogenomics

Pharmacogenomics is the study is about a person’s genes response to particular drugs. This is a somewhat new field that combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop productive, safe drugs and doses that will be bespoke to a person’s genetic makeup. This session plans to improve the novel drug administration by mixing drugs and modifying in light of hereditary varieties in placid reaction.

Session 10: Advanced Drug Delivery System

1. Vaccine Drug Delivery System

Vaccine is a material that activates an immunologically mediated resistance to a disease but not necessarily an infection. Vaccines generally consist of killed or attenuated organisms or subunits of organisms or DNA encoding antigenic proteins of pathogens. Delivery of antigens from oil-based adjuvants such as Freund's ancillary lead to a reduction in the number of doses of vaccine to be administered but due to toxicity concerns such as inductions of granulomas at the injection site, such ancillary is not widely used. Search for safer and potent ancillary resulted in the formulations of antigen into delivery systems that administer the antigen in particulate form rather than solution form.

Cancer vaccines

· Human vaccines

· HIV/AIDS vaccines

· HPV vaccines

· Therapeutic vaccination for autoimmune diseases

· Novel vaccines

· Clinical trials

2. Sustained Release Drug Delivery system

Sustained-release drug delivery dosage forms are designed to release a drug at a prearranged rate by maintaining a fixed drug level for a particular period of time with minimum side effects. It basically optimizes the biopharmaceutical, pharmacokinetic and pharmacodynamics properties of a drug in such a way that its utility is maximized, side-effects are reduced and the cure of the disease is achieved.

3. Prolonged Release Drug Delivery System

Prolonged-release drug delivery system makes a simple cylindrical device with a small release hole which is investigated by a dynamic mathematical simulation model based on the two-dimensional Fick's law of diffusion. Effects of the release hole radius, height, and radius of the device and hydrodynamic diffusion boundary layer formed on the device, the surface is numerically evaluated. It releases the active ingredients through a hole slowly so that it can release for an extended period of time.

Session 11: Green Sustainable Pharma

Green pharmacy is the scheme of pharmaceutical products and processes that eliminate or diminish naturally the use and generation of hazardous substances and the prevention/reduction of environmental/safety and health impacts at the source. A current pharmaceutical can be green in terms of the quality and quantity of waste generated during its synthesis. Sustainable pharmacy is a brand- new issue and approach. It focuses on environmental, economic and social aspects of pharmacy. It is concerned with the waste produced during the synthesis and production of an Active Pharmaceutical Ingredient. Moreover, it would also check on the compounds themselves and will aim to advance the degradability of the compounds after their use in the environment to diminish the environmental risk caused by pharmaceuticals in the environment. The main focus of this session is on the role of patients, doctors, and pharmacists in helping them to contribute more green and sustainable pharmacy by proper use of the pharmaceuticals.

Session 12: Proteomics in Drug Discovery

Drug discovery is an interminable and extraordinarily expensive process that uses a variety of tools from distinct fields. To promote the process, several biotechnologies, including genomics, proteomics, cellular and organismic methodologies have been advanced. The present review aims to provide a basic understanding of proteomics research by discussing the methods used to study large numbers of proteins and just by reviewing the application of proteomics process to identify biomarkers, to identify drug target and to conduct drug’s mode of action and toxicology studies. It is expected that this will add advantage to an important brand- new insights into disease mechanisms and enhance drug discovery strategies to produce novel therapeutics.

Session 13: Pharmacognosy and Phytochemistry

Pharmacognosy deals with the study of drugs where the origin is natural. It gives information about the states of the drug, such as the physical-chemical biochemical and biological characteristics of a drug. Phytochemistry is the study of chemicals comes from the plants. The biochemical obtained from plants undergoes several processes such as identified, purified, biosynthesized and further, are used as biologically active compounds in Indian traditional medicine, Chinese medicine.

· Pharma: just trying to start something new with the help of Digital.

· Digital Pharma: A New Culture

· Digital Pharma & Customer Service

· Digital Pharma Opportunities & Challenges

· Digital’s Increasing Impact on Pharma Communications

Session 14: Digital Pharma

Pharmaceutical companies can play a paramount role in the digital revolution of healthcare. But grabbing this opportunity requires identifying the right actions. Pharmaceutical companies are running hard to keep measure with changes brought about by digital technology. Mobile communications, the cloud, advanced analytics, and the Internet of Things are among the new innovations that are starting to transform the healthcare industry in the ways they have already transformed the media, retail, and banking industries. Pharma executives are well aware of the disturbing potential and are examining with a wide range of digital enterprise. Yet many find it hard to determine what initiatives to scale up and how, as they are still unclear what digital success will look like five years from now. This article aims to remedy that. The digital pharma market is relied on upon to reach $ 11.2 billion in 2013. This market is further anticipated that would develop up to $23.5 billion in 2018 with a compound yearly development rate (CAGR) of 16.1%.

Session 15: Control Quality of Analytical Methods

Analytical quality control refers to the sum up of processes and procedures designed to satisfy that the results of laboratory analysis are persistent, proportionate, and authentic and within the specified bound of precision. Qualitative analysis specifies the measurement of the concentration of the element or compound in a matrix that differs from the element or compound.

Session 16: Pharmaceutical Manufacturing

Drug manufacturing is the process done by pharmaceutical companies for the synthesis of pharmaceutical drugs. The process of drug manufacturing undergoes into a number of series of unit operations, such as milling, granulation, coating, tablet pressing, and others.

Session 17: Bio-availability and Bio-equivalence

Bioavailability is the measure of the drug extent of a therapeutically active medicine that reaches the systemic circulation when injected in the body and is accordingly available at the site of action. Bioequivalence is pharmacokinetics terms it describes the feature where if two drugs have identical active intents and have similar bioavailability and produce the same purpose at the place of result.

The measurement of both bioavailability and bioequivalence is crucial to ensure constancy in standards of quality, efficacy &safety of

The measurement of both bioavailability and bioequivalence is crucial to ensure constancy in standards of quality, efficacy &safety of Pharmaceutical dosage forms.

· BA/BE Studies

· Bioequivalence Cardiovascular Products

· Bioequivalence Study Design

· Bioequivalence Study Protocols

· Invitro Bioequivalence

· Universal Bioavailability

· Bioavailability Metrics

· Waiver of invivo Bioavailability

Session 18: Pharmaceutical Chemistry

Pharmaceutical Chemistry is the study of drugs to optimize pharmacokinetics and pharmacodynamics, and synthesis of new drug molecules (Medicinal Chemistry). Pharmaceutical Chemistry is a branch of chemistry that deals with delivery, absorption, metabolism and, etc. It includes synthesis/isolation, identification, structural elucidation, structural modification, structural activity relationship (SAR) studies. It is the study of the chemical characteristics, biochemical changes after drug administration and their effects along with analysis of drugs.

Session 19: Biologics and Biosimilars

Biologics is a drug which is made from living cells through highly complex manufacturing processes and must be carefully handled and must be supervised under carefully monitoring conditions. Biologics are basically used to prevent, treat, diagnose, or cure a collection of diseases which include cancer, chronic kidney disease, autoimmune disorders, and infectious diseases. A biosimilar is exactly what its name resembles — it is a biologic that is “similar” to another biologic drug which is already approved by the FDA. Under U.S. law, a biosimilar is approved only when it shows is “highly similar” to an FDA-approved biological product, known as a reference product. It is not necessary that it may have any clinically meaningful differences in terms of safety and effectiveness from the reference product.

Session 20: Nanomedicine and Biomedical Applications

Nanomedicine is a nanotechnology application in a healthcare setting. And it’s already seen nanoparticles to improve the behavior of drug substances and in drug delivery. It’s already seen that nanomedicine and biomedical applications are used globally to improve the treatments methods and lives of patients suffering from a range of disorders including ovarian and breast cancer, kidney disease, fungal infections, elevated cholesterol, menopausal symptoms, multiple sclerosis, chronic pain, asthma, and emphysema.

For more information visit: Pharmaceutical Conferences

Scope of nanomedicine

· Novel drugs to Nano drugs

· Nanomedicine for other diseases

· Nanomedicine for gastrointestinal tract (GI) diseases

· Nanomedicine for CNS

· Nanomedicine for blood disorders

· Nanomedicine for lung diseases

· Nanomedicine for cardiovascular diseases

· Future aspects of nanomedicine

· Nano drugs for herbal medicines and cosmetics

Session 21: Encapsulated Drugs

It is a very advanced approach in which the drug/small molecules are nanoencapusaluted in nanocarriers (NCs). The basic idea about encapsulate drug is it allows efficient loading of drug molecules inside the NCs which in further reduces systemic toxicity associated with drugs.

Session 22: Pharmacy Law and Ethics

Law is a rule of conduct that is formally recognized by a society as binding and is enforced by that society. Ethics, on the other hand, are less structured and less formal. As professionals, pharmacists must use their professional skills for the benefit of their patients.

AGENDA

Please see picture below

Organizing Committee

Dr. Ian Martins

Edith Cowan University

Queensland, Australia

Rashid Mahmood

General Manager Technical Operations, Surge Laboratories Private Limited

SURGE Laboratories Private Limited

Bhikhi, Pakistan

Ranjit Barshikar

"Instituto de Assistência Médica ao Servidor Público Estadual" (IAMSPE)

Brazil city, Brazil

Vitaly Ovchinnikov

Kazan national research technical university

Kazan, Russia

Dr D.V. Gokhale

Emeritus Scientist

National Chemical Laboratory

Mumbai, India

Dr. Joel I. Osorio

CEO

RegenerAge Clinic

Mexico, Mexico

Dr. Carolle-Laure KPOUMIE

Industrie pharma

Paris, France

Dr. Alain L Fymat BA, BS, MA, MS, PhD

President/CEO and Professor , Gynecology

International Institute of Medicine and Science, Inc.

California, USA

Oleg D. Linnikov

Head of the laboratory

Russian Academy of Sciences

Federal City, Russia

Takashiro Akitsu

Professor, Department of Chemistry

Tokyo University of Science

Shinjuku, Japan

Mr. Alejandro De la Parra Solomon

CEO

WAMS(The World Academy of Medical Sciences)

Mexico, Mexico

"Please contact the event manager Marilyn (marilyn.b.turner@nyeventslist.com ) below for:

- Multiple participant discounts

- Price quotations or visa invitation letters

- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)

- Event sponsorships

NO REFUNDS ALLOWED ON REGISTRATIONS

Service fees included in this listing.

-----------------------------------------------------------------

Allied Academies - New York Events List

http://www.NyEventsList.com

http://www.BostonEventsList.com

http://www.SFBayEventsList.com

-----------------------------------------------------------------

MYL191029CEV"

Share with friends

Date and Time

Location

Venue will be informed to the Registered Participants

TBA

00100 Rome

Italy

View Map

Save This Event

Event Saved